Olsson B - Search Results

1

Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a MRE11 variant.

Sedghi M, Salari M, Moslemi AR, Kariminejad A, Davis M, Goullée H, Olsson B, Laing N, Tajsharghi H. Sedghi M, et al. Among authors: olsson b. Neurol Genet. 2018 Dec 3;4(6):e295. doi: 10.1212/NXG.0000000000000295. eCollection 2018 Dec. Neurol Genet. 2018. PMID: 30584599 Free PMC article.

2

Truncating CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant of multiple pterygium syndrome.

Kariminejad A, Almadani N, Khoshaeen A, Olsson B, Moslemi AR, Tajsharghi H. Kariminejad A, et al. Among authors: olsson b. BMC Genet. 2016 May 31;17(1):71. doi: 10.1186/s12863-016-0382-5. BMC Genet. 2016. PMID: 27245440 Free PMC article.

3

Verification of microRNA expression in human endometrial adenocarcinoma.

Jurcevic S, Klinga-Levan K, Olsson B, Ejeskär K. Jurcevic S, et al. Among authors: olsson b. BMC Cancer. 2016 Apr 2;16:261. doi: 10.1186/s12885-016-2296-z. BMC Cancer. 2016. PMID: 27039384 Free PMC article.

4

Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues.

Carlsson J, Helenius G, Karlsson M, Lubovac Z, Andrén O, Olsson B, Klinga-Levan K. Carlsson J, et al. Among authors: olsson b. Cancer Genet Cytogenet. 2010 Oct 15;202(2):71-5. doi: 10.1016/j.cancergencyto.2010.06.009. Cancer Genet Cytogenet. 2010. PMID: 20875868

5

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K. Karlsson E, et al. Among authors: olsson b. BMC Cancer. 2008 Sep 8;8:254. doi: 10.1186/1471-2407-8-254. BMC Cancer. 2008. PMID: 18778486 Free PMC article.

6

High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.

Möllerström E, Delle U, Danielsson A, Parris T, Olsson B, Karlsson P, Helou K. Möllerström E, et al. Among authors: olsson b. Cancer Genet Cytogenet. 2010 Apr 15;198(2):79-89. doi: 10.1016/j.cancergencyto.2009.12.012. Cancer Genet Cytogenet. 2010. PMID: 20362222

7

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Osterberg L, Levan K, Partheen K, Delle U, Olsson B, Sundfeldt K, Horvath G. Osterberg L, et al. Among authors: olsson b. BMC Cancer. 2009 Oct 18;9:368. doi: 10.1186/1471-2407-9-368. BMC Cancer. 2009. PMID: 19835627 Free PMC article.

8

Validation of suitable endogenous control genes for quantitative PCR analysis of microRNA gene expression in a rat model of endometrial cancer.

Jurcevic S, Olsson B, Klinga-Levan K. Jurcevic S, et al. Among authors: olsson b. Cancer Cell Int. 2013 May 16;13(1):45. doi: 10.1186/1475-2867-13-45. Cancer Cell Int. 2013. PMID: 23680393 Free PMC article.

9

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.

Carlsson J, Helenius G, Karlsson MG, Andrén O, Klinga-Levan K, Olsson B. Carlsson J, et al. Among authors: olsson b. BMC Cancer. 2013 Jul 29;13:362. doi: 10.1186/1471-2407-13-362. BMC Cancer. 2013. PMID: 23890084 Free PMC article.

10

MicroRNA expression in human endometrial adenocarcinoma.

Jurcevic S, Olsson B, Klinga-Levan K. Jurcevic S, et al. Among authors: olsson b. Cancer Cell Int. 2014 Nov 14;14(1):88. doi: 10.1186/s12935-014-0088-6. eCollection 2014. Cancer Cell Int. 2014. PMID: 25419182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters